HBM Healthcare (Switzerland) Performance
HBMN Stock | CHF 199.40 0.40 0.20% |
HBM Healthcare has a performance score of 7 on a scale of 0 to 100. The firm retains a Market Volatility (i.e., Beta) of -0.13, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning HBM Healthcare are expected to decrease at a much lower rate. During the bear market, HBM Healthcare is likely to outperform the market. HBM Healthcare Inves at this time retains a risk of 1.66%. Please check out HBM Healthcare standard deviation, total risk alpha, treynor ratio, as well as the relationship between the jensen alpha and sortino ratio , to decide if HBM Healthcare will be following its current trending patterns.
Risk-Adjusted Performance
7 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in HBM Healthcare Investments are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, HBM Healthcare may actually be approaching a critical reversion point that can send shares even higher in March 2025. ...more
Begin Period Cash Flow | 6 M | |
Total Cashflows From Investing Activities | 50 M |
HBM |
HBM Healthcare Relative Risk vs. Return Landscape
If you would invest 18,200 in HBM Healthcare Investments on November 3, 2024 and sell it today you would earn a total of 1,740 from holding HBM Healthcare Investments or generate 9.56% return on investment over 90 days. HBM Healthcare Investments is generating 0.1684% of daily returns and assumes 1.6595% volatility on return distribution over the 90 days horizon. Simply put, 14% of stocks are less volatile than HBM, and 97% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
Risk |
HBM Healthcare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for HBM Healthcare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as HBM Healthcare Investments, and traders can use it to determine the average amount a HBM Healthcare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1015
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | HBMN | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
1.66 actual daily | 14 86% of assets are more volatile |
Expected Return
0.17 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average HBM Healthcare is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of HBM Healthcare by adding it to a well-diversified portfolio.
HBM Healthcare Fundamentals Growth
HBM Stock prices reflect investors' perceptions of the future prospects and financial health of HBM Healthcare, and HBM Healthcare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on HBM Stock performance.
Return On Equity | -0.25 | |||
Return On Asset | -0.14 | |||
Operating Margin | 1.00 % | |||
Current Valuation | 2.49 B | |||
Shares Outstanding | 6.96 M | |||
Price To Earning | 10.40 X | |||
Price To Book | 0.78 X | |||
Price To Sales | 4.28 X | |||
Revenue | (76.5 M) | |||
EBITDA | (75.31 M) | |||
Cash And Equivalents | 5.39 M | |||
Cash Per Share | 0.73 X | |||
Total Debt | 148.92 M | |||
Debt To Equity | 12.70 % | |||
Book Value Per Share | 253.59 X | |||
Cash Flow From Operations | (10.2 M) | |||
Earnings Per Share | (11.22) X | |||
Total Asset | 2.14 B | |||
About HBM Healthcare Performance
Evaluating HBM Healthcare's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if HBM Healthcare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if HBM Healthcare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies. The fund exits its portfolio companies through trade sale or IPO. HBM Healthcare operates under Biotechnology classification in Switzerland and is traded on Switzerland Exchange.Things to note about HBM Healthcare Inves performance evaluation
Checking the ongoing alerts about HBM Healthcare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for HBM Healthcare Inves help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.HBM Healthcare Investments has accumulated 148.92 M in total debt with debt to equity ratio (D/E) of 12.7, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. HBM Healthcare Inves has a current ratio of 0.09, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist HBM Healthcare until it has trouble settling it off, either with new capital or with free cash flow. So, HBM Healthcare's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like HBM Healthcare Inves sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for HBM to invest in growth at high rates of return. When we think about HBM Healthcare's use of debt, we should always consider it together with cash and equity. | |
Net Loss for the year was (78.03 M) with loss before overhead, payroll, taxes, and interest of (73.78 M). | |
HBM Healthcare Investments has accumulated about 5.39 M in cash with (10.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.73. | |
Roughly 17.0% of HBM Healthcare shares are held by company insiders |
- Analyzing HBM Healthcare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether HBM Healthcare's stock is overvalued or undervalued compared to its peers.
- Examining HBM Healthcare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating HBM Healthcare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of HBM Healthcare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of HBM Healthcare's stock. These opinions can provide insight into HBM Healthcare's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for HBM Stock Analysis
When running HBM Healthcare's price analysis, check to measure HBM Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HBM Healthcare is operating at the current time. Most of HBM Healthcare's value examination focuses on studying past and present price action to predict the probability of HBM Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HBM Healthcare's price. Additionally, you may evaluate how the addition of HBM Healthcare to your portfolios can decrease your overall portfolio volatility.